AKOS037652256 can be used as a TRPML modulator for the treatment of diseases associated with TRPML activity such as lysosomal accumulation disorders, muscular dystrophy, common age-related neurodegenerative diseases, oxidative stress or reactive oxygen species (ROS)-related diseases and ageing.

Limocitrin 3,7-diglucoside is a flavonoid isolated from Sedum sarmentosum.

Achyranthoside D is a triterpene saponin from Achyranthes root.